Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Nano-X Imaging Ltd. (NNOX) Financial Statements

Nano-X Imaging Ltd. (NNOX) reported trailing twelve-month revenue of $16.5M (up 34.9% year on year) and net income of -$75.0M as of 2026-09-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$45.0M.

Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason

NNOXNano-X Imaging Ltd.Follow NNOX — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
26.1M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
19 Nov, in 26 days

Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Sep 26.

LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Sep 26
Trend
Revenue0.30.39.911.313.016.5
Gross profit-1.5-6.9-6.6-10.6-12.8—
Research & development17.126.526.020.219.2—
Operating income-61.6-117.7-62.6-56.7-78.2—
Pre-tax income-61.8-116.9-61.1-53.9-76.8—
Income tax-0.0-3.7-0.3-0.4-1.8—
Net income-61.8-113.2-60.8-53.5-75.0—
Diluted EPS ($)—-2.17-1.08-0.91-1.16—
Diluted shares (mn)—52.256.458.764.8—

USD millions · SEC XBRL

Nano-X Imaging Ltd. — questions

What is Nano-X Imaging Ltd.'s revenue?
$16.5M over the twelve months to 2026-09-30, up 34.9% year on year, from its 10-Q and 10-K filings.
What is Nano-X Imaging Ltd.'s net income?
-$75.0M over the twelve months to 2026-09-30.
What is Nano-X Imaging Ltd.'s free cash flow?
-$45.0M over the twelve months to 2026-09-30.

Every figure on this page comes from Nano-X Imaging Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.